Abstract
PurposeTo report central serous chorioretinopathy associated with excessive use of compounds with sympathomimetic activity. DesignObservational case series. MethodsFour patients presented with clinical and fluorescein angiographic evidence of central serous chorioretinopathy. All patients expressed a concomitant psychogenic stress and high-dose ingestion of pseudoephedrine, oxymetazoline, or 3,4-methylenedioxymethamphetamine, all of which possess sympathomimetic properties. ResultsIn all cases, resolution of central serous chorioretinopathy coincided with cessation of the medication. ConclusionsPatients afflicted with central serous chorioretinopathy should be notified about its possible association with sympathomimetic medications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
